Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse MKT  >  ImmunoCellular Therapeutics Ltd    IMUC

Delayed Quote. Delayed  - 04/29 09:59:56 pm
0.255 USD   -5.56%
03/30 IMMUNOCELLULAR : Announces 2015 Financial Results
03/30 IMMUNOCELLULAR : Announces 2015 Financial Results
03/29 IMMUNOCELLULAR : to Report 2015 Financial Results on March 30, 2016
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse Mkt
04/25/2016 04/26/2016 04/27/2016 04/28/2016 04/29/2016 Date
0.274(c) 0.27(c) 0.2666(c) 0.27(c) 0.255(c) Last
292 584 216 180 91 925 134 593 311 641 Volume
+1.37% -1.46% -1.26% +1.28% -5.56% Change
More quotes
Financials ($)
Sales 2016 -
EBIT 2016 -30,5 M
Net income 2016 -30,8 M
Debt 2016 -
Yield 2016 -
Sales 2017 -
EBIT 2017 -29,1 M
Net income 2017 -29,4 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales 2016 0
Capi. / Sales 2017 0
Capitalization 24,8 M
More Financials
Company
ImmunoCellular Therapeutics Ltd. is a Los Angeles-based clinical-stage company that develops immune-based therapies for the treatment of brain and other cancers.ImmunoCellular's pipeline includes: ICT-121, a dendritic cell immunotherapy targeting the CD133 antigen on stem cells in recurrent... 
More about the company
Latest news on IMMUNOCELLULAR THERAPEUTIC
04/07 IMMUNOCELLULAR THERAPEUTICS : Announces 2015 Financial Results
03/30 IMMUNOCELLULAR THERAPEUTICS : Results of Operations and Financial Condition, Fin..
03/30 IMMUNOCELLULAR THERAPEUTICS : Announces 2015 Financial Results
03/30 IMMUNOCELLULAR THERAPEUTICS : Announces 2015 Financial Results
03/29 IMMUNOCELLULAR THERAPEUTICS : to Report 2015 Financial Results on March 30, 2016
03/10 CRYOPORT : Supports ImmunoCellular Therapeutics' 120-Site Phase III Clinical Tri..
03/07 IMMUNOCELLULAR THERAPEUTICS : to Present at ROTH Conference on March 16, 2016
03/03 IMMUNOCELLULAR THERAPEUTICS : Cryoport Supports ImmunoCellular Therapeutics' 120..
More news
Sector news : Biotechnology & Medical Research - NEC
04/29 SANOFI : offers to buy Medivation for $9.3bn
04/29 SANOFI : France's Sanofi makes $9.3 billion bid for US cancer drug giant
04/29DJSanofi Seeks Talks With Medivation Over $9.3 Billion Offer -- 2nd Update
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
03/31 ImmunoCellular Therapeutics' (IMUC) CEO Andrew Gengos on Q4 2015 Results - Ea..
03/31 ImmunoCellular Therapeutics reports FY15 results
03/30 ImmunoCellular Therapeutics EPS in-line
01/18 With Approval Likely, Celldex Needs To Expand Commercial Capabilities
01/04 PREMARKET BIOTECH DIGEST : Akebia In Focus, VIVUS's Positive Spin, Pershing's Va..


Comments 
Advertisement
Chart IMMUNOCELLULAR THERAPEUTIC
Duration : Period :
ImmunoCellular Therapeutic Technical Analysis Chart | IMUC | US4525361055 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions